NLRP3 and inflammatory bowel disease: Given the readily accessible nature of BMSCs and their sustained proliferative capacity under in vitro culture conditions, our research has focused on BMSCs-Exo to elucidate their therapeutic potential in mitigating NLRP3/Caspase-1/GSDMD-mediated pyroptosis of IECs and ameliorating IBD.